Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes
G-quadruplex (G4) structures are key elements in the regulation of cancer cell proliferation and their targeting is deemed to be a promising strategy in anticancer therapy. A tandem application of ligand-based virtual screening (VS) calculations together with the experimental G-quadruplex on Oligo A...
Saved in:
Published in | Biochimica et biophysica acta. General subjects Vol. 1861; no. 5; pp. 1341 - 1352 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.05.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | G-quadruplex (G4) structures are key elements in the regulation of cancer cell proliferation and their targeting is deemed to be a promising strategy in anticancer therapy.
A tandem application of ligand-based virtual screening (VS) calculations together with the experimental G-quadruplex on Oligo Affinity Support (G4-OAS) assay was employed to discover novel G4-targeting compounds. The interaction of the selected compounds with the investigated G4 in solution was analysed through a series of biophysical techniques and their biological activity investigated by immunofluorescence and MTT assays.
A focused library of 60 small molecules, designed as putative G4 groove binders, was identified through the VS. The G4-OAS experimental screening led to the selection of 7 ligands effectively interacting with the G4-forming human telomeric DNA. Evaluation of the biological activity of the selected compounds showed that 3 ligands of this sub-library induced a marked telomere-localized DNA damage response in human tumour cells.
The combined application of virtual and experimental screening tools proved to be a successful strategy to identify new bioactive chemotypes able to target the telomeric G4 DNA. These compounds may represent useful leads for the development of more potent and selective G4 ligands.
Expanding the repertoire of the available G4-targeting chemotypes with improved physico-chemical features, in particular aiming at the discovery of novel, selective G4 telomeric ligands, can help in developing effective anti-cancer drugs with fewer side effects. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio.
[Display omitted]
•60 putative G-quadruplex binders were identified by ligand-based virtual screening.•G4-OAS assay led to the selection of 7 effective ligands of telomeric G-quadruplex.•3 compounds were able to induce a significant DNA damage response at telomeres.•DNA damage caused by treatment with compound 10B correlates with cytotoxic activity. |
---|---|
AbstractList | G-quadruplex (G4) structures are key elements in the regulation of cancer cell proliferation and their targeting is deemed to be a promising strategy in anticancer therapy.
A tandem application of ligand-based virtual screening (VS) calculations together with the experimental G-quadruplex on Oligo Affinity Support (G4-OAS) assay was employed to discover novel G4-targeting compounds. The interaction of the selected compounds with the investigated G4 in solution was analysed through a series of biophysical techniques and their biological activity investigated by immunofluorescence and MTT assays.
A focused library of 60 small molecules, designed as putative G4 groove binders, was identified through the VS. The G4-OAS experimental screening led to the selection of 7 ligands effectively interacting with the G4-forming human telomeric DNA. Evaluation of the biological activity of the selected compounds showed that 3 ligands of this sub-library induced a marked telomere-localized DNA damage response in human tumour cells.
The combined application of virtual and experimental screening tools proved to be a successful strategy to identify new bioactive chemotypes able to target the telomeric G4 DNA. These compounds may represent useful leads for the development of more potent and selective G4 ligands.
Expanding the repertoire of the available G4-targeting chemotypes with improved physico-chemical features, in particular aiming at the discovery of novel, selective G4 telomeric ligands, can help in developing effective anti-cancer drugs with fewer side effects. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio.
[Display omitted]
•60 putative G-quadruplex binders were identified by ligand-based virtual screening.•G4-OAS assay led to the selection of 7 effective ligands of telomeric G-quadruplex.•3 compounds were able to induce a significant DNA damage response at telomeres.•DNA damage caused by treatment with compound 10B correlates with cytotoxic activity. G-quadruplex (G4) structures are key elements in the regulation of cancer cell proliferation and their targeting is deemed to be a promising strategy in anticancer therapy.A tandem application of ligand-based virtual screening (VS) calculations together with the experimental G-quadruplex on Oligo Affinity Support (G4-OAS) assay was employed to discover novel G4-targeting compounds. The interaction of the selected compounds with the investigated G4 in solution was analysed through a series of biophysical techniques and their biological activity investigated by immunofluorescence and MTT assays.A focused library of 60 small molecules, designed as putative G4 groove binders, was identified through the VS. The G4-OAS experimental screening led to the selection of 7 ligands effectively interacting with the G4-forming human telomeric DNA. Evaluation of the biological activity of the selected compounds showed that 3 ligands of this sub-library induced a marked telomere-localized DNA damage response in human tumour cells.The combined application of virtual and experimental screening tools proved to be a successful strategy to identify new bioactive chemotypes able to target the telomeric G4 DNA. These compounds may represent useful leads for the development of more potent and selective G4 ligands.Expanding the repertoire of the available G4-targeting chemotypes with improved physico-chemical features, in particular aiming at the discovery of novel, selective G4 telomeric ligands, can help in developing effective anti-cancer drugs with fewer side effects. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio. G-quadruplex (G4) structures are key elements in the regulation of cancer cell proliferation and their targeting is deemed to be a promising strategy in anticancer therapy. A tandem application of ligand-based virtual screening (VS) calculations together with the experimental G-quadruplex on Oligo Affinity Support (G4-OAS) assay was employed to discover novel G4-targeting compounds. The interaction of the selected compounds with the investigated G4 in solution was analysed through a series of biophysical techniques and their biological activity investigated by immunofluorescence and MTT assays. A focused library of 60 small molecules, designed as putative G4 groove binders, was identified through the VS. The G4-OAS experimental screening led to the selection of 7 ligands effectively interacting with the G4-forming human telomeric DNA. Evaluation of the biological activity of the selected compounds showed that 3 ligands of this sub-library induced a marked telomere-localized DNA damage response in human tumour cells. The combined application of virtual and experimental screening tools proved to be a successful strategy to identify new bioactive chemotypes able to target the telomeric G4 DNA. These compounds may represent useful leads for the development of more potent and selective G4 ligands. Expanding the repertoire of the available G4-targeting chemotypes with improved physico-chemical features, in particular aiming at the discovery of novel, selective G4 telomeric ligands, can help in developing effective anti-cancer drugs with fewer side effects. This article is part of a Special Issue entitled "G-quadruplex" Guest Editor: Dr. Concetta Giancola and Dr. Daniela Montesarchio. |
Author | Cingolani, Chiara Randazzo, Antonio Biroccio, Annamaria Giancola, Concetta Cosconati, Sandro Amato, Jussara Zizza, Pasquale Novellino, Ettore Musumeci, Domenica Pagano, Bruno Montesarchio, Daniela Platella, Chiara |
Author_xml | – sequence: 1 givenname: Domenica surname: Musumeci fullname: Musumeci, Domenica organization: Department of Chemical Sciences, University of Naples Federico II, Naples 80126, Italy – sequence: 2 givenname: Jussara surname: Amato fullname: Amato, Jussara organization: Department of Pharmacy, University of Naples Federico II, Naples 80131, Italy – sequence: 3 givenname: Pasquale surname: Zizza fullname: Zizza, Pasquale organization: Oncogenomic and Epigenetic Unit, Regina Elena National Cancer Institute, Rome 00144, Italy – sequence: 4 givenname: Chiara surname: Platella fullname: Platella, Chiara organization: Department of Chemical Sciences, University of Naples Federico II, Naples 80126, Italy – sequence: 5 givenname: Sandro surname: Cosconati fullname: Cosconati, Sandro organization: DiSTABiF, Second University of Naples, Caserta 81100, Italy – sequence: 6 givenname: Chiara surname: Cingolani fullname: Cingolani, Chiara organization: Oncogenomic and Epigenetic Unit, Regina Elena National Cancer Institute, Rome 00144, Italy – sequence: 7 givenname: Annamaria surname: Biroccio fullname: Biroccio, Annamaria organization: Oncogenomic and Epigenetic Unit, Regina Elena National Cancer Institute, Rome 00144, Italy – sequence: 8 givenname: Ettore surname: Novellino fullname: Novellino, Ettore organization: Department of Pharmacy, University of Naples Federico II, Naples 80131, Italy – sequence: 9 givenname: Antonio surname: Randazzo fullname: Randazzo, Antonio organization: Department of Pharmacy, University of Naples Federico II, Naples 80131, Italy – sequence: 10 givenname: Concetta surname: Giancola fullname: Giancola, Concetta organization: Department of Pharmacy, University of Naples Federico II, Naples 80131, Italy – sequence: 11 givenname: Bruno surname: Pagano fullname: Pagano, Bruno email: bruno.pagano@unina.it organization: Department of Pharmacy, University of Naples Federico II, Naples 80131, Italy – sequence: 12 givenname: Daniela surname: Montesarchio fullname: Montesarchio, Daniela email: daniela.montesarchio@unina.it organization: Department of Chemical Sciences, University of Naples Federico II, Naples 80126, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28130159$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1u1DAURi1URKctb4CQl2wSfB3njwVSVbUDUqUuaNeW49wMHiV2ajsj8vZ4mMKCBXhjyT7nyv6-C3JmnUVC3gHLgUH1cZ93ndqhzTmDOmeQMy5ekQ00Nc8axqozsmEFE5mAqjwnFyHsWVplW74h57yBgkHZbsj6qGyPE1XzPBqtonGWuoGOZpfOs04F7OnB-LiokQbtEa2xO5ru6FZkD9ffqApBrTQ6anq00Qwrte6AI91mz4vq_TKP-COLyu8wHk39HScX1xnDFXk9qDHg25f9kjzd3T7efMnuH7Zfb67vM120Zcx0ev7QY8WbSnHFOK9bSL_AptUAwOsSRF00RQcCUXQoQPMWWiGgL7SuKiwuyYfT3Nm75wVDlJMJGsdRWXRLkJyJsuGsqEVC37-gSzdhL2dvJuVX-TuuBIgToL0LwePwBwEmj63IvTy1Io-tSAYytZK0T39p2sRfWUevzPg_-fNJxhTSwaCXQRu0GnvjUUfZO_PvAT8BhgWqDA |
CitedBy_id | crossref_primary_10_3390_ijms221910624 crossref_primary_10_1021_acs_jcim_4c01132 crossref_primary_10_3390_ijms24044070 crossref_primary_10_1016_j_biochi_2018_06_024 crossref_primary_10_3390_molecules23020493 crossref_primary_10_1016_j_phrs_2024_107381 crossref_primary_10_1038_s41598_023_39675_5 crossref_primary_10_1002_chem_202101229 crossref_primary_10_1021_acs_jmedchem_1c00125 crossref_primary_10_1016_j_biopha_2021_111550 crossref_primary_10_1016_j_biochi_2018_02_004 crossref_primary_10_1021_acs_jcim_1c01021 crossref_primary_10_1007_s10462_021_10071_7 crossref_primary_10_1016_j_bioorg_2020_103862 crossref_primary_10_1016_j_ijbiomac_2020_11_013 crossref_primary_10_2174_1573406414666180524071409 crossref_primary_10_1016_j_cej_2024_154947 crossref_primary_10_1016_j_bbagen_2017_03_022 crossref_primary_10_3390_ijms21061964 crossref_primary_10_2174_0929867324666171116123345 crossref_primary_10_1016_j_ejmech_2018_11_058 crossref_primary_10_1039_D4TC04766D crossref_primary_10_3390_pharmaceutics15051414 crossref_primary_10_1093_nar_gkaa1001 crossref_primary_10_1002_open_202200090 crossref_primary_10_1093_bioinformatics_btae365 crossref_primary_10_3390_pharmaceutics13101611 crossref_primary_10_1021_acs_joc_3c01903 crossref_primary_10_1002_ejoc_202200718 crossref_primary_10_1016_j_bbamcr_2019_118539 crossref_primary_10_1080_07391102_2023_2240416 crossref_primary_10_1016_j_aca_2018_04_071 crossref_primary_10_1002_cmdc_201900243 crossref_primary_10_1007_s11030_021_10217_3 crossref_primary_10_3390_ph14080769 crossref_primary_10_3390_ijms23073784 crossref_primary_10_1039_D1OB01995C crossref_primary_10_1021_acs_analchem_8b04677 crossref_primary_10_3390_ijms222111959 |
Cites_doi | 10.1002/path.2500 10.1016/j.bmc.2014.05.030 10.1093/nar/gnh015 10.1038/nchembio.780 10.1007/128_2012_331 10.1039/b607707b 10.1021/jm401185b 10.1039/c003428b 10.1021/jm301019w 10.1021/ci049714+ 10.1038/nchem.1548 10.2174/138161212799958396 10.1016/S0959-440X(03)00072-1 10.1093/nar/24.5.829 10.1016/j.molcel.2005.05.008 10.1038/350718a0 10.2174/138161212799958332 10.1093/nar/gkv862 10.1021/jm0603365 10.1016/S0959-8049(97)00057-9 10.1007/128_2012_347 10.1021/acs.jmedchem.5b01835 10.1172/JCI32461 10.1021/jm050555a 10.1016/S0959-8049(02)00139-9 10.1039/c1cs15117g 10.1111/j.1742-4658.2009.07463.x 10.1006/jmra.1995.1047 10.1093/nar/gkm522 10.1038/onc.2010.344 10.1023/A:1008272928075 10.1016/j.biochi.2008.03.006 10.1021/acs.jcim.5b00658 10.1002/jcc.20084 10.1021/ja062791w 10.1073/pnas.82.5.1376 10.1021/acs.jmedchem.6b00129 10.3389/fchem.2014.00054 10.1021/ja075710k 10.1021/ac500444m 10.1002/cmdc.201402552 |
ContentType | Journal Article |
Copyright | 2017 Elsevier B.V. Copyright © 2017 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier B.V. – notice: Copyright © 2017 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7S9 L.6 |
DOI | 10.1016/j.bbagen.2017.01.024 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed AGRICOLA AGRICOLA - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry Biology |
EISSN | 1872-8006 |
EndPage | 1352 |
ExternalDocumentID | 28130159 10_1016_j_bbagen_2017_01_024 S0304416517300326 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 23N 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABEFU ABFNM ABGSF ABMAC ABUDA ABXDB ABYKQ ACDAQ ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEHWI AEKER AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DOVZS EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OHT OZT P-8 P-9 PC. Q38 R2- ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UQL WH7 WUQ XJT XPP ~G- AAHBH AATTM AAXKI AAYWO AAYXX ABWVN ACRPL ACVFH ADCNI ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP BNPGV CITATION SSH CGR CUY CVF ECM EFKBS EIF NPM 7S9 L.6 |
ID | FETCH-LOGICAL-c395t-c165fde6286a2a022791059e89c111275147383b14ee4be41c2919441d3cc66e3 |
IEDL.DBID | .~1 |
ISSN | 0304-4165 |
IngestDate | Fri Jul 11 09:23:08 EDT 2025 Mon Jul 21 05:42:28 EDT 2025 Tue Jul 01 00:22:08 EDT 2025 Thu Apr 24 22:57:11 EDT 2025 Fri Feb 23 02:34:16 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Virtual screening Anticancer agents Drug discovery G-quadruplex |
Language | English |
License | Copyright © 2017 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c395t-c165fde6286a2a022791059e89c111275147383b14ee4be41c2919441d3cc66e3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 28130159 |
PQID | 2045820374 |
PQPubID | 24069 |
PageCount | 12 |
ParticipantIDs | proquest_miscellaneous_2045820374 pubmed_primary_28130159 crossref_primary_10_1016_j_bbagen_2017_01_024 crossref_citationtrail_10_1016_j_bbagen_2017_01_024 elsevier_sciencedirect_doi_10_1016_j_bbagen_2017_01_024 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | May 2017 2017-05-00 2017-May 20170501 |
PublicationDateYYYYMMDD | 2017-05-01 |
PublicationDate_xml | – month: 05 year: 2017 text: May 2017 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Biochimica et biophysica acta. General subjects |
PublicationTitleAlternate | Biochim Biophys Acta Gen Subj |
PublicationYear | 2017 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Musumeci (bb0095) 2014; 86 De Boeck, Forsyth, Praet, Hogendoorn (bb0005) 2009; 217 Moore, Cuenca, Searcey, Neidle (bb0080) 2006; 4 Thiriet, Hayes (bb0140) 2005; 18 Hawkins, Skillman, Nicholls (bb0180) 2007; 50 Cavalluzzi, Borer (bb0190) 2004; 32 Kopka, Yoon, Goodsell, Pjura, Dickerson (bb0165) 1985; 82 Luu, Phan, Kuryavyi, Lacroix, Patel (bb0160) 2006; 128 Dalvit (bb0200) 1998; 11 Irwin, Shoichet (bb0175) 2005; 45 Biffi, Tannahill, McCafferty, Balasubramanian (bb0015) 2013; 5 Rhodes, Lipps (bb0150) 2015; 43 Pagano (bb0085) 2008; 90 Zahler, Williamson, Cech, Prescott (bb0025) 1991; 350 Kim (bb0020) 1997; 33 Ali, Bhattacharya (bb0035) 2014; 22 Masiero (bb0120) 2010; 8 Jain, Bhattacharya (bb0060) 2012; 18 Pettersen (bb0185) 2004; 25 Murat, Singh, Defrancq (bb0115) 2011; 40 Randazzo, Spada, Webba Da Silva (bb0125) 2013 Neidle (bb0045) 2016; 59 Zaffaroni (bb0090) 2002; 38 Giancola, Pagano (bb0135) 2013; 330 Dai, Carver, Punchihewa, Jones, Yang (bb0100) 2007; 35 Neidle, Parkinson (bb0010) 2003; 13 Salvati (bb0205) 2010; 29 Di Leva (bb0070) 2013; 56 Kaserer, Rigo, Schuster, Alcaro, Sissi, Schuster (bb0105) 2016; 56 Amato, Morigi, Pagano, Pagano, Ohnmacht, De Magis, Tiang, Capranico, Locatelli, Graziadio, Leoni, Rambaldi, Novellino, Neidle, Randazzo (bb0055) 2016; 59 Pagano (bb0130) 2015; 10 Rodriguez (bb0145) 2012; 8 Cosconati (bb0065) 2012; 55 Martino (bb0075) 2007; 129 Pagano (bb0110) 2012; 18 Neidle (bb0030) 2010; 277 Jaroszewski, Clausen, Cohen, Dahl (bb0170) 1996; 24 Hwang, Shaka (bb0195) 1995; 112 Salvati (bb0155) 2007; 117 Moore (bb0040) 2006 Amato, Iaccarino, Pagano, Morigi, Locatelli, Leoni, Rambaldi, Zizza, Biroccio, Novellino, Randazzo (bb0050) 2014; 2 Amato (10.1016/j.bbagen.2017.01.024_bb0050) 2014; 2 Rodriguez (10.1016/j.bbagen.2017.01.024_bb0145) 2012; 8 Zaffaroni (10.1016/j.bbagen.2017.01.024_bb0090) 2002; 38 Salvati (10.1016/j.bbagen.2017.01.024_bb0155) 2007; 117 Jaroszewski (10.1016/j.bbagen.2017.01.024_bb0170) 1996; 24 Neidle (10.1016/j.bbagen.2017.01.024_bb0010) 2003; 13 Pagano (10.1016/j.bbagen.2017.01.024_bb0130) 2015; 10 Cosconati (10.1016/j.bbagen.2017.01.024_bb0065) 2012; 55 Di Leva (10.1016/j.bbagen.2017.01.024_bb0070) 2013; 56 Cavalluzzi (10.1016/j.bbagen.2017.01.024_bb0190) 2004; 32 Biffi (10.1016/j.bbagen.2017.01.024_bb0015) 2013; 5 Thiriet (10.1016/j.bbagen.2017.01.024_bb0140) 2005; 18 Pettersen (10.1016/j.bbagen.2017.01.024_bb0185) 2004; 25 Neidle (10.1016/j.bbagen.2017.01.024_bb0030) 2010; 277 Dai (10.1016/j.bbagen.2017.01.024_bb0100) 2007; 35 Dalvit (10.1016/j.bbagen.2017.01.024_bb0200) 1998; 11 Martino (10.1016/j.bbagen.2017.01.024_bb0075) 2007; 129 Pagano (10.1016/j.bbagen.2017.01.024_bb0110) 2012; 18 De Boeck (10.1016/j.bbagen.2017.01.024_bb0005) 2009; 217 Kaserer (10.1016/j.bbagen.2017.01.024_bb0105) 2016; 56 Salvati (10.1016/j.bbagen.2017.01.024_bb0205) 2010; 29 Kim (10.1016/j.bbagen.2017.01.024_bb0020) 1997; 33 Pagano (10.1016/j.bbagen.2017.01.024_bb0085) 2008; 90 Masiero (10.1016/j.bbagen.2017.01.024_bb0120) 2010; 8 Ali (10.1016/j.bbagen.2017.01.024_bb0035) 2014; 22 Murat (10.1016/j.bbagen.2017.01.024_bb0115) 2011; 40 Rhodes (10.1016/j.bbagen.2017.01.024_bb0150) 2015; 43 Neidle (10.1016/j.bbagen.2017.01.024_bb0045) 2016; 59 Hwang (10.1016/j.bbagen.2017.01.024_bb0195) 1995; 112 Kopka (10.1016/j.bbagen.2017.01.024_bb0165) 1985; 82 Zahler (10.1016/j.bbagen.2017.01.024_bb0025) 1991; 350 Hawkins (10.1016/j.bbagen.2017.01.024_bb0180) 2007; 50 Amato (10.1016/j.bbagen.2017.01.024_bb0055) 2016; 59 Moore (10.1016/j.bbagen.2017.01.024_bb0080) 2006; 4 Giancola (10.1016/j.bbagen.2017.01.024_bb0135) 2013; 330 Musumeci (10.1016/j.bbagen.2017.01.024_bb0095) 2014; 86 Luu (10.1016/j.bbagen.2017.01.024_bb0160) 2006; 128 Jain (10.1016/j.bbagen.2017.01.024_bb0060) 2012; 18 Randazzo (10.1016/j.bbagen.2017.01.024_bb0125) 2013; 330 Moore (10.1016/j.bbagen.2017.01.024_bb0040) 2006; 49 Irwin (10.1016/j.bbagen.2017.01.024_bb0175) 2005; 45 |
References_xml | – volume: 129 start-page: 16048 year: 2007 end-page: 16056 ident: bb0075 article-title: Structural and thermodynamic studies of the interaction of distamycin A with the parallel quadruplex structure [d(TGGGGT)] publication-title: J. Am. Chem. Soc. – volume: 56 start-page: 9646 year: 2013 end-page: 9654 ident: bb0070 article-title: Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence publication-title: J. Med. Chem. – volume: 18 start-page: 617 year: 2005 end-page: 622 ident: bb0140 article-title: Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair publication-title: Mol. Cell – volume: 56 start-page: 484 year: 2016 end-page: 500 ident: bb0105 article-title: Optimized virtual screening workflow for the identification of novel G-quadruplex ligands publication-title: J. Chem. Inf. Model. – volume: 4 start-page: 3479 year: 2006 end-page: 3488 ident: bb0080 article-title: Synthesis of distamycin A polyamides targeting G-quadruplex DNA publication-title: Org. Biomol. Chem. – volume: 38 start-page: 1792 year: 2002 end-page: 1801 ident: bb0090 article-title: Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells publication-title: Eur. J. Cancer – volume: 13 start-page: 275 year: 2003 end-page: 283 ident: bb0010 article-title: The structure of telomeric DNA publication-title: Curr. Opin. Struct. Biol. – volume: 40 start-page: 5293 year: 2011 end-page: 5307 ident: bb0115 article-title: Methods for investigating G-quadruplex DNA/ligand interactions publication-title: Chem. Soc. Rev. – volume: 59 start-page: 5987 year: 2016 end-page: 6011 ident: bb0045 article-title: Quadruplex nucleic acids as novel therapeutic targets publication-title: J. Med. Chem. – volume: 35 start-page: 4927 year: 2007 end-page: 4940 ident: bb0100 article-title: Structure of the hybrid-2 type intramolecular human telomeric G-quadruplex in K publication-title: Nucleic Acids Res. – volume: 33 start-page: 781 year: 1997 end-page: 786 ident: bb0020 article-title: Clinical implications of telomerase in cancer publication-title: Eur. J. Cancer Part A – start-page: 582 year: 2006 end-page: 599 ident: bb0040 article-title: Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation publication-title: J. Med. Chem. – volume: 50 start-page: 74 year: 2007 end-page: 82 ident: bb0180 article-title: Comparison of shape-matching and docking as virtual screening tools publication-title: J. Med. Chem. – volume: 25 start-page: 1605 year: 2004 end-page: 1612 ident: bb0185 article-title: UCSF Chimera: a visualization system for exploratory research and analysis publication-title: J. Comput. Chem. – volume: 18 start-page: 1880 year: 2012 end-page: 1899 ident: bb0110 article-title: State-of-the-art methodologies for the discovery and characterization of DNA G-quadruplex binders publication-title: Curr. Pharm. Des. – volume: 330 start-page: 211 year: 2013 end-page: 242 ident: bb0135 article-title: Energetics of ligand binding to G-quadruplexes publication-title: Top. Curr. Chem. – volume: 217 start-page: 327 year: 2009 end-page: 344 ident: bb0005 article-title: Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms publication-title: J. Pathol. – volume: 24 start-page: 829 year: 1996 end-page: 834 ident: bb0170 article-title: NMR investigations of duplex stability of phosphorothioate and phosphorodithioate DNA analogues modified in both strands publication-title: Nucleic Acids Res. – volume: 32 start-page: 1 year: 2004 end-page: 9 ident: bb0190 article-title: Revised UV extinction coefficients for nucleoside-5′-monophosphates and unpaired DNA and RNA publication-title: Nucleic Acids Res. – volume: 43 start-page: 8627 year: 2015 end-page: 8637 ident: bb0150 article-title: G-quadruplexes and their regulatory roles in biology publication-title: Nucleic Acids Res. – volume: 10 start-page: 640 year: 2015 end-page: 649 ident: bb0130 article-title: Looking for efficient G-quadruplex ligands: evidence for selective stabilizing properties and telomere damage by drug-like molecules publication-title: ChemMedChem – start-page: 67 year: 2013 end-page: 86 ident: bb0125 article-title: Circular dichroism of quadruplex structures publication-title: Top. Curr. Chem. – volume: 55 start-page: 9785 year: 2012 end-page: 9792 ident: bb0065 article-title: A. Shooting for selective drug-like G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death publication-title: J. Med. Chem. – volume: 8 start-page: 301 year: 2012 end-page: 310 ident: bb0145 article-title: Small-molecule-induced DNA damage identifies alternative DNA structures in human genes publication-title: Nat. Chem. Biol. – volume: 45 start-page: 177 year: 2005 end-page: 182 ident: bb0175 article-title: ZINC − a free database of commercially available compounds for virtual screening publication-title: J. Chem. Inf. Model. – volume: 29 start-page: 6280 year: 2010 end-page: 6293 ident: bb0205 article-title: PARP1 activated at telomeres upon G4 stabilization: possible target for telomere-based therapy publication-title: Oncogene – volume: 8 start-page: 2683 year: 2010 end-page: 2692 ident: bb0120 article-title: A non-empirical chromophoric interpretation of CD spectra of DNA G-quadruplex structures publication-title: Org. Biomol. Chem. – volume: 277 start-page: 1118 year: 2010 end-page: 1125 ident: bb0030 article-title: Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer publication-title: FEBS J. – volume: 59 start-page: 5706 year: 2016 end-page: 5720 ident: bb0055 article-title: Toward the development of specific G-quadruplex binders: synthesis, biophysical, and biological studies of new hydrazone derivatives publication-title: J. Med. Chem. – volume: 82 start-page: 1376 year: 1985 end-page: 1380 ident: bb0165 article-title: The molecular origin of DNA-drug specificity in netropsin and distamycin publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 18 start-page: 1917 year: 2012 end-page: 1933 ident: bb0060 article-title: Recent developments in the chemistry and biology of G-quadruplexes with reference to the DNA groove binders publication-title: Curr. Pharm. Des. – volume: 5 start-page: 182 year: 2013 end-page: 186 ident: bb0015 article-title: Quantitative visualization of DNA G-quadruplex structures in human cells publication-title: Nat. Chem. – volume: 22 start-page: 4506 year: 2014 end-page: 4521 ident: bb0035 article-title: DNA binders in clinical trials and chemotherapy publication-title: Bioorg. Med. Chem. – volume: 2 start-page: 54 year: 2014 ident: bb0050 article-title: Bis-indole derivatives with antitumor activity turn out to be specific ligands of human telomeric G-quadruplex publication-title: Front. Chem. – volume: 11 start-page: 437 year: 1998 end-page: 444 ident: bb0200 article-title: Efficient multiple-solvent suppression for the study of the interactions of organic solvents with biomolecules publication-title: J. Biomol. NMR – volume: 117 start-page: 3236 year: 2007 end-page: 3247 ident: bb0155 article-title: Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect publication-title: J. Clin. Invest. – volume: 86 start-page: 4126 year: 2014 end-page: 4130 ident: bb0095 article-title: G-quadruplex on Oligo Affinity Support (G4-OAS): an easy affinity chromatography-based assay for the screening of G-quadruplex ligands publication-title: Anal. Chem. – volume: 128 start-page: 9963 year: 2006 end-page: 9970 ident: bb0160 article-title: Structure of the human telomere in K publication-title: J. Am. Chem. Soc. – volume: 350 start-page: 718 year: 1991 end-page: 720 ident: bb0025 article-title: Inhibition of telomerase by G-quartet DNA structures publication-title: Nature – volume: 112 start-page: 275 year: 1995 end-page: 279 ident: bb0195 article-title: Water suppression that works. Excitation sculpting using arbitrary waveforms and pulsed field gradients publication-title: J. Magn. Reson. A – volume: 90 start-page: 1224 year: 2008 end-page: 1232 ident: bb0085 article-title: Targeting DNA quadruplexes with distamycin A and its derivatives: an ITC and NMR study publication-title: Biochimie – volume: 217 start-page: 327 year: 2009 ident: 10.1016/j.bbagen.2017.01.024_bb0005 article-title: Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms publication-title: J. Pathol. doi: 10.1002/path.2500 – volume: 22 start-page: 4506 year: 2014 ident: 10.1016/j.bbagen.2017.01.024_bb0035 article-title: DNA binders in clinical trials and chemotherapy publication-title: Bioorg. Med. Chem. doi: 10.1016/j.bmc.2014.05.030 – volume: 32 start-page: 1 year: 2004 ident: 10.1016/j.bbagen.2017.01.024_bb0190 article-title: Revised UV extinction coefficients for nucleoside-5′-monophosphates and unpaired DNA and RNA publication-title: Nucleic Acids Res. doi: 10.1093/nar/gnh015 – volume: 8 start-page: 301 year: 2012 ident: 10.1016/j.bbagen.2017.01.024_bb0145 article-title: Small-molecule-induced DNA damage identifies alternative DNA structures in human genes publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.780 – volume: 330 start-page: 67 year: 2013 ident: 10.1016/j.bbagen.2017.01.024_bb0125 article-title: Circular dichroism of quadruplex structures publication-title: Top. Curr. Chem. doi: 10.1007/128_2012_331 – volume: 4 start-page: 3479 year: 2006 ident: 10.1016/j.bbagen.2017.01.024_bb0080 article-title: Synthesis of distamycin A polyamides targeting G-quadruplex DNA publication-title: Org. Biomol. Chem. doi: 10.1039/b607707b – volume: 56 start-page: 9646 year: 2013 ident: 10.1016/j.bbagen.2017.01.024_bb0070 article-title: Exploring the chemical space of G-quadruplex binders: discovery of a novel chemotype targeting the human telomeric sequence publication-title: J. Med. Chem. doi: 10.1021/jm401185b – volume: 8 start-page: 2683 year: 2010 ident: 10.1016/j.bbagen.2017.01.024_bb0120 article-title: A non-empirical chromophoric interpretation of CD spectra of DNA G-quadruplex structures publication-title: Org. Biomol. Chem. doi: 10.1039/c003428b – volume: 55 start-page: 9785 year: 2012 ident: 10.1016/j.bbagen.2017.01.024_bb0065 article-title: A. Shooting for selective drug-like G-quadruplex binders: evidence for telomeric DNA damage and tumor cell death publication-title: J. Med. Chem. doi: 10.1021/jm301019w – volume: 45 start-page: 177 year: 2005 ident: 10.1016/j.bbagen.2017.01.024_bb0175 article-title: ZINC − a free database of commercially available compounds for virtual screening publication-title: J. Chem. Inf. Model. doi: 10.1021/ci049714+ – volume: 5 start-page: 182 year: 2013 ident: 10.1016/j.bbagen.2017.01.024_bb0015 article-title: Quantitative visualization of DNA G-quadruplex structures in human cells publication-title: Nat. Chem. doi: 10.1038/nchem.1548 – volume: 18 start-page: 1917 year: 2012 ident: 10.1016/j.bbagen.2017.01.024_bb0060 article-title: Recent developments in the chemistry and biology of G-quadruplexes with reference to the DNA groove binders publication-title: Curr. Pharm. Des. doi: 10.2174/138161212799958396 – volume: 13 start-page: 275 year: 2003 ident: 10.1016/j.bbagen.2017.01.024_bb0010 article-title: The structure of telomeric DNA publication-title: Curr. Opin. Struct. Biol. doi: 10.1016/S0959-440X(03)00072-1 – volume: 24 start-page: 829 year: 1996 ident: 10.1016/j.bbagen.2017.01.024_bb0170 article-title: NMR investigations of duplex stability of phosphorothioate and phosphorodithioate DNA analogues modified in both strands publication-title: Nucleic Acids Res. doi: 10.1093/nar/24.5.829 – volume: 18 start-page: 617 year: 2005 ident: 10.1016/j.bbagen.2017.01.024_bb0140 article-title: Chromatin in need of a fix: phosphorylation of H2AX connects chromatin to DNA repair publication-title: Mol. Cell doi: 10.1016/j.molcel.2005.05.008 – volume: 350 start-page: 718 year: 1991 ident: 10.1016/j.bbagen.2017.01.024_bb0025 article-title: Inhibition of telomerase by G-quartet DNA structures publication-title: Nature doi: 10.1038/350718a0 – volume: 18 start-page: 1880 year: 2012 ident: 10.1016/j.bbagen.2017.01.024_bb0110 article-title: State-of-the-art methodologies for the discovery and characterization of DNA G-quadruplex binders publication-title: Curr. Pharm. Des. doi: 10.2174/138161212799958332 – volume: 43 start-page: 8627 year: 2015 ident: 10.1016/j.bbagen.2017.01.024_bb0150 article-title: G-quadruplexes and their regulatory roles in biology publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkv862 – volume: 50 start-page: 74 year: 2007 ident: 10.1016/j.bbagen.2017.01.024_bb0180 article-title: Comparison of shape-matching and docking as virtual screening tools publication-title: J. Med. Chem. doi: 10.1021/jm0603365 – volume: 33 start-page: 781 year: 1997 ident: 10.1016/j.bbagen.2017.01.024_bb0020 article-title: Clinical implications of telomerase in cancer publication-title: Eur. J. Cancer Part A doi: 10.1016/S0959-8049(97)00057-9 – volume: 330 start-page: 211 year: 2013 ident: 10.1016/j.bbagen.2017.01.024_bb0135 article-title: Energetics of ligand binding to G-quadruplexes publication-title: Top. Curr. Chem. doi: 10.1007/128_2012_347 – volume: 59 start-page: 5987 year: 2016 ident: 10.1016/j.bbagen.2017.01.024_bb0045 article-title: Quadruplex nucleic acids as novel therapeutic targets publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b01835 – volume: 117 start-page: 3236 year: 2007 ident: 10.1016/j.bbagen.2017.01.024_bb0155 article-title: Telomere damage induced by the G-quadruplex ligand RHPS4 has an antitumor effect publication-title: J. Clin. Invest. doi: 10.1172/JCI32461 – volume: 49 start-page: 582 year: 2006 ident: 10.1016/j.bbagen.2017.01.024_bb0040 article-title: Trisubstituted acridines as G-quadruplex telomere targeting agents. Effects of extensions of the 3,6- and 9-side chains on quadruplex binding, telomerase activity, and cell proliferation publication-title: J. Med. Chem. doi: 10.1021/jm050555a – volume: 38 start-page: 1792 year: 2002 ident: 10.1016/j.bbagen.2017.01.024_bb0090 article-title: Inhibition of telomerase activity by a distamycin derivative: effects on cell proliferation and induction of apoptosis in human cancer cells publication-title: Eur. J. Cancer doi: 10.1016/S0959-8049(02)00139-9 – volume: 40 start-page: 5293 year: 2011 ident: 10.1016/j.bbagen.2017.01.024_bb0115 article-title: Methods for investigating G-quadruplex DNA/ligand interactions publication-title: Chem. Soc. Rev. doi: 10.1039/c1cs15117g – volume: 277 start-page: 1118 year: 2010 ident: 10.1016/j.bbagen.2017.01.024_bb0030 article-title: Human telomeric G-quadruplex: the current status of telomeric G-quadruplexes as therapeutic targets in human cancer publication-title: FEBS J. doi: 10.1111/j.1742-4658.2009.07463.x – volume: 112 start-page: 275 year: 1995 ident: 10.1016/j.bbagen.2017.01.024_bb0195 article-title: Water suppression that works. Excitation sculpting using arbitrary waveforms and pulsed field gradients publication-title: J. Magn. Reson. A doi: 10.1006/jmra.1995.1047 – volume: 35 start-page: 4927 year: 2007 ident: 10.1016/j.bbagen.2017.01.024_bb0100 article-title: Structure of the hybrid-2 type intramolecular human telomeric G-quadruplex in K+ solution: insights into structure polymorphism of the human telomeric sequence publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkm522 – volume: 29 start-page: 6280 year: 2010 ident: 10.1016/j.bbagen.2017.01.024_bb0205 article-title: PARP1 activated at telomeres upon G4 stabilization: possible target for telomere-based therapy publication-title: Oncogene doi: 10.1038/onc.2010.344 – volume: 11 start-page: 437 year: 1998 ident: 10.1016/j.bbagen.2017.01.024_bb0200 article-title: Efficient multiple-solvent suppression for the study of the interactions of organic solvents with biomolecules publication-title: J. Biomol. NMR doi: 10.1023/A:1008272928075 – volume: 90 start-page: 1224 year: 2008 ident: 10.1016/j.bbagen.2017.01.024_bb0085 article-title: Targeting DNA quadruplexes with distamycin A and its derivatives: an ITC and NMR study publication-title: Biochimie doi: 10.1016/j.biochi.2008.03.006 – volume: 56 start-page: 484 year: 2016 ident: 10.1016/j.bbagen.2017.01.024_bb0105 article-title: Optimized virtual screening workflow for the identification of novel G-quadruplex ligands publication-title: J. Chem. Inf. Model. doi: 10.1021/acs.jcim.5b00658 – volume: 25 start-page: 1605 year: 2004 ident: 10.1016/j.bbagen.2017.01.024_bb0185 article-title: UCSF Chimera: a visualization system for exploratory research and analysis publication-title: J. Comput. Chem. doi: 10.1002/jcc.20084 – volume: 128 start-page: 9963 year: 2006 ident: 10.1016/j.bbagen.2017.01.024_bb0160 article-title: Structure of the human telomere in K+ solution: an intramolecular (3+1) G-quadruplex scaffold publication-title: J. Am. Chem. Soc. doi: 10.1021/ja062791w – volume: 82 start-page: 1376 year: 1985 ident: 10.1016/j.bbagen.2017.01.024_bb0165 article-title: The molecular origin of DNA-drug specificity in netropsin and distamycin publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.82.5.1376 – volume: 59 start-page: 5706 year: 2016 ident: 10.1016/j.bbagen.2017.01.024_bb0055 article-title: Toward the development of specific G-quadruplex binders: synthesis, biophysical, and biological studies of new hydrazone derivatives publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.6b00129 – volume: 2 start-page: 54 year: 2014 ident: 10.1016/j.bbagen.2017.01.024_bb0050 article-title: Bis-indole derivatives with antitumor activity turn out to be specific ligands of human telomeric G-quadruplex publication-title: Front. Chem. doi: 10.3389/fchem.2014.00054 – volume: 129 start-page: 16048 year: 2007 ident: 10.1016/j.bbagen.2017.01.024_bb0075 article-title: Structural and thermodynamic studies of the interaction of distamycin A with the parallel quadruplex structure [d(TGGGGT)]4 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja075710k – volume: 86 start-page: 4126 year: 2014 ident: 10.1016/j.bbagen.2017.01.024_bb0095 article-title: G-quadruplex on Oligo Affinity Support (G4-OAS): an easy affinity chromatography-based assay for the screening of G-quadruplex ligands publication-title: Anal. Chem. doi: 10.1021/ac500444m – volume: 10 start-page: 640 year: 2015 ident: 10.1016/j.bbagen.2017.01.024_bb0130 article-title: Looking for efficient G-quadruplex ligands: evidence for selective stabilizing properties and telomere damage by drug-like molecules publication-title: ChemMedChem doi: 10.1002/cmdc.201402552 |
SSID | ssj0000595 |
Score | 2.401262 |
Snippet | G-quadruplex (G4) structures are key elements in the regulation of cancer cell proliferation and their targeting is deemed to be a promising strategy in... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1341 |
SubjectTerms | adverse effects Anticancer agents antineoplastic agents Antineoplastic Agents - chemistry Antineoplastic Agents - metabolism Antineoplastic Agents - pharmacology Binding Sites Cell Line, Transformed cell proliferation Cell Proliferation - drug effects Cell Survival - drug effects chemotypes DNA DNA damage DNA, Neoplasm - chemistry DNA, Neoplasm - drug effects DNA, Neoplasm - genetics DNA, Neoplasm - metabolism Dose-Response Relationship, Drug Drug Design Drug discovery fluorescent antibody technique G-quadruplex G-Quadruplexes - drug effects Guanosine - chemistry Guanosine - metabolism High-Throughput Screening Assays Humans Ligands Models, Molecular neoplasms Neoplasms - drug therapy Neoplasms - genetics Neoplasms - pathology screening Small Molecule Libraries Structure-Activity Relationship Telomere - chemistry Telomere - drug effects Telomere - genetics Telomere - metabolism telomeres Time Factors Virtual screening |
Title | Tandem application of ligand-based virtual screening and G4-OAS assay to identify novel G-quadruplex-targeting chemotypes |
URI | https://dx.doi.org/10.1016/j.bbagen.2017.01.024 https://www.ncbi.nlm.nih.gov/pubmed/28130159 https://www.proquest.com/docview/2045820374 |
Volume | 1861 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYQaAUXxHuBBRmJq2kcO3F7rKqFLmjhAEjcLMd2UFbdpFtaRC_8dmbihMcBIe0xjq1EM5OZbzIvQo65MXnMhWMujRWTsZOsm_mIRSbhWR7F1tTDJn5fpsNbeX6X3C2QQVsLg2mVje4POr3W1s1Kp6FmZ1wUnWsM6gGcSDi2XAcUghXsUqGUnzy_pXkAfEhCJEEy3N2Wz9U5XlkGHy12QeUqNO-Un5mnz-BnbYZO18hqgx9pP7ziOlnw5Qb5FiZKzjfI8qAd4LZJ5jf4g_gvfRejplVOR8U9rDM0X44-FhMsIKGgPMChBTNG4R49k-yqf00BV5s5nVa0qKt58zktq0c_omfs38y4yWw88k8spJLjSWA_8B382octcnv682YwZM2kBWZFL5kyC4TJnccyVRObuqsg4i7f7VnQhbECVKXAlc249F5mXnIb93gPqO-EtWnqxTZZLKvSfydURC61RsmuE05GmTTgMoncRFZ5kxib7hLREljbpg05TsMY6Tbf7I8ObNHIFh1xDWzZJez11Di04fhiv2p5pz-IkwZL8cXJo5bVGviF4RNT-mr2oLFxP-AloWDPTpCB13eJu4AFABnu_fdz98kKXoVcyh9kcTqZ-QPAO9PssBboQ7LU_3UxvHwB7Wv-bw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RUEUvFVDaUlpqJK5m49hJdo9oVdhSoAcWiZvl2A5KtU22yy7qXvrbmYkTSg8IqVc_FGvGnvkm8wI4EMYUsZCOuzTOuIqd4v3cRzwyiciLKLamaTZxfpGOrtTpdXK9AsMuF4bCKlvZH2R6I63bkV5Lzd60LHuX5NRDOJEIKrmOKOQFrCl8vtTG4PDP3zgPxA9JcCUoTsu7_LkmyCvP8dVSGVSRheqd6in99BT-bPTQ8Qa8bgEkOwpn3IQVX23By9BScrkF68Oug9sbWI7pD_FP9shJzeqCTcobHOekvxy7K2eUQcJQeqBFi3qM4Rw7Ufz70SVDYG2WbF6zsknnLZasqu_8hJ3wXwvjZovpxP_mIZacdiL_kfFo2N5uw9Xxl_FwxNtWC9zKQTLnFglTOE95qiY2TVlBAl6-P7AoDOMMYVWGtmwulPcq90rYeCAGSH4nrU1TL9_CalVX_j0wGbnUmkz1nXQqypVBm0kWJrKZN4mx6Q7IjsDatnXIqR3GRHcBZz90YIsmtuhIaGTLDvCHXdNQh-OZ9VnHO_3PfdKoKp7Zud-xWiO_yH9iKl8vbjVV7kfAJDNc8y7cgYezxH0EAwgNP_z3dz_D-mh8fqbPvl5824VXNBMCKz_C6ny28J8Q_MzzveZy3wOxUAAM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tandem+application+of+ligand-based+virtual+screening+and+G4-OAS+assay+to+identify+novel+G-quadruplex-targeting+chemotypes&rft.jtitle=Biochimica+et+biophysica+acta.+General+subjects&rft.au=Musumeci%2C+Domenica&rft.au=Amato%2C+Jussara&rft.au=Zizza%2C+Pasquale&rft.au=Platella%2C+Chiara&rft.date=2017-05-01&rft.pub=Elsevier+B.V&rft.issn=0304-4165&rft.eissn=1872-8006&rft.volume=1861&rft.issue=5&rft.spage=1341&rft.epage=1352&rft_id=info:doi/10.1016%2Fj.bbagen.2017.01.024&rft.externalDocID=S0304416517300326 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0304-4165&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0304-4165&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0304-4165&client=summon |